Research Ongoing

What does it cost our healthcare system when medications are not taken as prescribed?

Scientific Study Title:

Cost and burden of m edication non-adherence according to p rescribed dr u g spending and medica t ion us e rates (COMPUTE)

Start Date:

January 2021

End Date:

Ongoing

Research Category

# Arthritis Care, Health Habits & Wellbeing, Health Systems, Policies & Economics

Ready to Participate?

Life-changing arthritis research is only possible with your help!

Why do this research?

Reason For Research

Many Canadians use prescription medications to help them manage diseases such as diabetes, heart disease, and arthritis. The need for these medications continues to grow as our population ages. In Canada, we spent nearly $34 billion on prescription medications in 2019, making them the second most costly part of our healthcare system.

For medications to work, people need to take them as prescribed but, for many, this is a struggle. Although, we know how much medications are costing our healthcare system, we do not know how much it costs our healthcare system when medications are not taken as prescribed.

With Canadians pressing for a universal Pharmacare system, it is more important than ever to understand how medications are being taken in the real world. It is also important to know what it costs our healthcare system when medications are not taken as prescribed so that good policy decisions can be made.

Methodology

Execution of Research

We will look at healthcare data from the province of British Columbia to understand how top medications prescribed in Canada are being taken and identify what problems take place when medications are not taken as prescribed. Problems can include not following doses, not refilling prescriptions on time, and stopping prescriptions. We will learn whether problems like these lead to unavoidable healthcare costs in terms of visits to doctors, hospitals, and use of other medications.

Who is involved?

Involvement

Individuals included in “big data” on healthcare from the Province of British Columbia.

Results apply broadly to Canadian healthcare context?

Related Research

Are medications like Ozempic safe and effective for people with inflammatory arthritis and type 2 diabetes?

Evaluating a Decision Aid for Tapering Biologic Medications in Rheumatoid Arthritis

Development of a new life expectancy and quality of life prediction model for Canadians

What is the real risk of getting COVID-19, and how serious can it be, for British Columbians who are taking medications that affect their immune system?

Inflammatory Arthritis from Cancer Immunotherapy: A Canada-Wide Study

Making Strength Training Easy for People with Arthritis

2026 STUDIES TO WATCH

OUR RESEARCH

OUR TEAM

ARTHRITIS PATIENT ADVISORY BOARD

VOLUNTEER

PARTICIPATE IN RESEARCH

SHARE YOUR STORY